chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Puffy eyes; Itchy eyes; Redness eyes; Stomach ache; Little lightheaded/ dizzy; Disoriented; Didn't feel well; Headache; Nausea; Arm extremely painful; This spontaneous case was reported by a consumer and describes the occurrence of PERIORBITAL SWELLING (Puffy eyes), EYE PRURITUS (Itchy eyes), OCULAR HYPERAEMIA (Redness eyes), ABDOMINAL PAIN UPPER (Stomach ache) and PAIN IN EXTREMITY (Arm extremely painful) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm extremely painful). On 20-Feb-2021, the patient experienced PERIORBITAL SWELLING (Puffy eyes), EYE PRURITUS (Itchy eyes), OCULAR HYPERAEMIA (Redness eyes), ABDOMINAL PAIN UPPER (Stomach ache), DIZZINESS (Little lightheaded/ dizzy), DISORIENTATION (Disoriented), MALAISE (Didn't feel well), HEADACHE (Headache) and NAUSEA (Nausea). On 15-Feb-2021, PAIN IN EXTREMITY (Arm extremely painful) had resolved. At the time of the report, PERIORBITAL SWELLING (Puffy eyes), EYE PRURITUS (Itchy eyes), OCULAR HYPERAEMIA (Redness eyes), ABDOMINAL PAIN UPPER (Stomach ache), DIZZINESS (Little lightheaded/ dizzy), DISORIENTATION (Disoriented), MALAISE (Didn't feel well), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.   This case was linked to MOD-2021-037698 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up information received on 03-MAY-2021 contains significant information: Added new events "Stomach ache", "Disoriented", "Didn't feel well".
While out dining on 5/17 Pt has (2) brief jerking movements, stiffened up, eyes open. No convulsing, normal breathing, not responding to commands. EMT called - lasted a few minutes but stopped prior to EMT arrival. Taking to ED T-102.5
3days p/vax pt vomit; to clinic; 7/2/99 pt pale, listless, dehydrated, no stools x1 day;hosp;pt screaming, bowels hyper w/bloody mucous; air-contrast enema dx & reduced intussusception. 7/3 pt exp bloody stools;surgery for nodule & resectio
This spontaneous report was received from a physician regarding a 47 year old patient with no pertinent medical history reported who on 19-AUG-2013 was vaccinated with ZOSTAVAX (lot number and expiration date not reported) (dose and route not specified). Concomitant medications included an unspecified influenza virus vaccine (manufacturer unknown) administered on 19-AUG-2013. Additional information has been requested.
This spontaneous report was received from a registered nurse and refers to multiple unspecified patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On multiple unspecified dates, the patients were vaccinated with doses of improperly stored LIQUID PEDVAXHIB lot # reported as M046140 with expiration date on 27-SEP-2019 (dose and route of administration were not reported). The vaccine underwent a temperature excursion of 9 to 25 degrees Celsius for 32 minutes. Digital data logger was used to record the excursion. The vaccine did not undergo any previous temperature excursions. No adverse effects were reported. This is one of two reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1705USA006315:
Approx 1 mo p/recvd flu vax, resident became difficult to arouse, verbally unresponsive 10DEC91 pt gradually improved 11DEC-14DEC91 then worsened on 15DEC91 & expired;
Patient was given the wrong dose; he was given 0.2mL instead of the 0.3mL of the vaccine. Patient was informed to wait 15min due to this being his first dosing, that's when he stated that this was his second dose and had received the Janssen and Janssen vaccine for his first dose.
Was walking in store approximately 20 minutes after immunization per patient and his wife - began with intermittent sharp/stabbing type muscle pain bilateral posterior calves with walking and last night with stretching his leg out on the bed caused the sharp pain.
Upon receiving the first dose, I had the usual reaction of a sore arm which faded after two-three days. Five-six days later, exactly eight days after I received my injection, I developed Covid arm. Pain at the injection site, a rash on the arm, skin was warm to the touch, and the area was swollen. The pain, rash, warmth and swelling are going down.
The day after the vaccination I took him to doctor.  Sore throat, fever , chest pain.  No strep and no Covid-19 .  One day later he Developed a very bad cough that will not go away.  Sounds like he?s coughing up his lungs.  Took Meds but not helping.  Prior to vaccination he was a Very normal healthy. He Very rarely got sick. I?m concerned about the terrible cough that won?t go away. He scares others with the violent coughing.
pt rcvd vax; t101.8 & had sz; adm hosp; c/o sepsis and/or vaccine reaction
This spontaneous report was received from a physician and a medical assistant, via a company representative, referring to a 67 year old female patient. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported. 20-NOV-2017, the patient was vaccinated with PNEUMOVAX 23 one injection of 0.5 ml intramuscularly in the arm, lot # N020501, expiration date on 03-MAR-2019, previously reported as lot # NO23651, expiration date on an unknown date in May 2019, for vaccination per CDC guidelines (strength was not reported). On 21-NOV-2017, reported as a day later, the patient experienced red ringed rash with heat at the injection site. On the same day, the patient also experienced large knot, redness, swelling and tenderness that lasted 4 days. The patient sought medical attention and called the physician who advised the patient to take an unspecified dose of the over-the-counter antihistamine cetirizine hydrochloride (ZYRTEC) as treatment, also reported by the medical assistant as no medication was prescript as treatment for the adverse event; conflicting information. At the time of reporting, the outcome of the injections site warmth and injection site rash was unknown. The outcome of large knot, redness, swelling and tenderness was reported as resolved on 25-NOV-2017. Additionally, the causality assessment between events and PNEUMOVAX 23 was not provided. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1711USA010085:
administrator applied pressure; little blood on the bandage; 2 inch by 1 inch bruise on her arm; wondering if the vaccine has been administered intramuscularly; had to hold pressure because blood came out a little bit; This is a spontaneous report from a contactable Nurse. A 70-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via intramuscular, administered in Arm Left on 24Feb2021 (Age at Vaccination 70-years-old) as single dose for COVID-19 immunization. Medical history included arterial stent insertion from 2011 and ongoing Verbatim: coronary artery stent. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN CHILDREN) taken for ischaemic heart disease prophylaxis from an unspecified start date and ongoing. Patient took first dose of bnt162b2 for COVID-19 Immunization. The patient experienced had to hold pressure because blood came out a little bit on 24Feb2021. The patient experienced administrator applied pressure, little blood on the bandage, 2 inch by 1 inch bruise on her arm and wondering if the vaccine has been administered intramuscularly on an unspecified date.it was reported that After the second dose, the administrator applied pressure and the caller noticed there was a little blood on the bandage. She stated it did not hurt a whole lot and my range of motion was ok. Caller states she was on Aspirin. 6 days later, on 02Mar2021, she noticed a 2 inch by 1 inch bruise on her arm. Caller was wondering if the vaccine has been administered intramuscularly and if the efficacy would be different. She is a little concerned. She hasnt been working in the nursing home because she was 70. She got the second vaccine on the twenty fourth. The person that gave it to her had to hold pressure because blood came out a little bit. She hasnt been able to see the area. She was concerned enough vaccine didnt go into the muscle. The person that gave it to her had to hold pressure because blood came out a little bit. She hasnt been able to see the area. She is concerned enough vaccine didn't go into the muscle. She is not sure if she got enough of the vaccine to produce antibodies since it bled. Caller clarified vaccine as COVID19 Vaccine. The first dose didn't bleed. She just wants to make sure she has enough antibodies. Caller clarified that she was calling to see what the efficacy to produce antibodies would be because she bled when receiving the vaccine. COVID19 Vaccine: had to hold pressure because blood came out a little bit related. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
I have muscle twitching after the second Pfizer shot and more than a year still twitching not went away; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old male patient received BNT162b2 (BNT162B2), on 14Apr2021 as dose 2, single (Lot number: Er8729), in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Er8733, Location of injection: Arm Right, Vaccine Administration Time: 11:00 AM), administration date: 23Mar2021, when the patient was 40-year-old, for Covid-19 immunization. The following information was reported: MUSCLE TWITCHING (non-serious) with onset 26Apr2021 at 10:00, outcome "not recovered", described as "I have muscle twitching after the second Pfizer shot and more than a year still twitching not went away".  Additional information: : Patient had muscle twitching after the second Pfizer shot and more than a year still twitching did not got away.
Sever Body Pains, muscle aches, unable to hold anything with hands, joint pains, nausea, loss of appetite.
COVID19 BOOST SHOT, LEFT SHOULDER PROGRESSIVE PAIN AND STIFFNESS SINCE DEC 1, 2021 ASSOCIATED WITH A PROGRESSIVE LOSS SHOULDER RANGE OF MOTION
Vaccines were given on Wed, Nov 3, 2022. The child had a mild rash all over body begging on Nov 5. On November 8, pts feet and leg became swollen to the point where she could not fit into her shoes and could not tolerate walking. Pt. taken to ER where she received a single dose of Steroids. On Tuesday Nov 9, pt taken back to ER for widespread large, swollen hives. Pt. prescribed a full taper dose of Steroids. Pt. did not experience any respiratory distress during this series of events.
left side of her face around the cheekbone feels like it is kind of numbing and tingling; left side of her face around the cheekbone feels like it is kind of numbing and tingling; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) and PARAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced HYPOAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) and PARAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling). At the time of the report, HYPOAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) and PARAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medication include allergy meds  No treatment information was provided
10 days after MOP noticed redness at site of injection.  Left side.  Redness increased in size within 24 hours after noticing.
This spontaneous report was received from a consumer (patient mother) refers to a female patient of unknown age. On 31-JUL-2008, the patient was vaccinated with the first dose of GARDASIL (dose, route and frequency was not reported). On 02-OCT-2008, the patient was vaccinated with the second dose of GARDASIL (dose, route and frequency was not reported). On 01-DEC-2008, the patient was vaccinated with the third dose of GARDASIL (dose, route and frequency was not reported). No AE reported. No further information ws provided. Additional information has been requested.
Received vaccine on 12/31/2020, developed mild arm pain following day at injection site. On 1/05/2021, developed mild lip swelling around 1630, that increased to hives on upper back and hips. At 2030, lip swelling had significantly increased and throat felt ?weird? and tight. Fiancé drove to Emergency Department, was deemed not necessary to have epinephrine at the time. Discharged with four day course of prednisone and famotidine. On 1/09/2021, returned to Emergency Department for bilateral hand swelling, increased hives on arms, back and sides.  Epinephrine 0.3 mg administered IM right thigh, discharged with another script for prednisone. There were no other changes to lifestyle including lotions, body washes, perfumes, food, etc. that could have potentially triggers reaction.
This case was reported by a healthcare professional and described the occurrence of injection site cellulitis in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). In July 2014, the subject received an unspecified dose of KINRIX (unknown route and injection site, batch number not provided). In July 2014, less than 2 weeks after vaccination with KINRIX, the subject experienced swelling injection site and possible injection site cellulitis. This case was associated to a product complaint. This case was assessed as medically serious by GSK. The subject was treated with antibiotics and steroids. At the time of reporting, the outcomes of the events were unspecified. The healthcare professional considered the events were probably related to vaccination with KINRIX. The reporter reported 2 other cases of swelling injection site after vaccination with KINRIX (cases A1083482A and A1083483A). These cases were associated to a product complaint since the reporter said that these cases happened in a relatively short period of time so she was afraid they were related to a specific lot of the vaccine.
1 of 2 pts who exp an inject site react following vax, 1 day p/ the inject site was sore, warm & pruritic; pt recvd pneumococcal vax 8 yrs previous;
Patient received her second Pfizer vaccine on Friday (6/4). She developed CP and SOB on Saturday (6/5) evening which resolved after sleeping. She then developed return of her chest pain and shortness of breath this morning (6/7) which prompted her to present to  ED. She was found to have elevated troponins and was diagnosed with myocarditis.   Treatment was supportive with NSAIDs/Tylenol for chest pain PRN and encouraged PO hydration. Troponins and EKGs trended every 8 hours to ensure troponins were down-trending and EKGs remained normal. No sign of CHF or pulmonary edema.
Rash maculopapular head to toe. No fever. No current rash/lesions.
From initial information received on 4/5/04 from the vaccine provider regarding an adverse event occurring in the USA, it was reported that a 33 year old female patient received a third dose of IMOVAX RABIES vaccination, lot number W0136, route and site of administration unknown, on 3/10/04. Two days later, on 3/12/04, the patient experienced palpitation and discomfort. Her titers reached 1:50 on 3/17/04. It was reported that her signs and symptoms resolved and that she recovered from these events. The patient receievd the first dose of an IMOVAX RABIES vaccination, lot number U0971, route and site of administration unknown, on 3/4/04. The only known information on the second dose is the lot number, which was provided as 330011, manufacturer and route and site of administration unknown, on 3/7/04. From follow up information received on 4/7/04 from the reporting physician through a telephone contact, it was reported that the patient admits to drinking several cups of coffee on 3/12/04 and for this reason the physician felt the palpitations were more likely caused by the caffeine and not the vaccine. The lot number for the third dose of vaccine was also confirmed as W0136, dose two was given in the emergency room, therefore she was not able to verify the lot number at this time, but she has requested the emergency room records from the hospital. The rabies vaccine was administered because the patient's dog was attacked by a unknown wild animal in a rural area and because she sleeps with her dog, this made her very anxious. The patient requested the rabies series be given, even though the physician did not feel it was needed. The physician agreed to call back when the hospital records were obtained. No other information was reported. From information received on 5/5/04 from a health care professional, no additional information was provided. No further information is anticipated, this case is considered closed. A correction to the date of vaccination was made in box 10 of the report. The date of vaccination was reported as 5/10/04, but entered in error as 3/30/04.
documentation on client's chart reflects client received Pfizer Bivalent for 6mo-4yr old, lot# GK1667, dose 3mcg/0.2 mL in 2mL injection to left deltoid. Client and his mother agreed to receive the proper dose for 5 year old which should have been Pfizer Bivalent for 5-11 year old, lot number GK1657, dose 10mcg/0.2 mL. This nurse believes the client received the proper dose and an error was made in charting . Nevertheless, the incorrect dose was charted and uploaded to system.  Error was discovered 7/31/23 upon client's return to clinic. Client's mother reported no obvious side effects or distress after vaccination.
From initial information received on 4/13/04 from the patient regarding an adverse event occurring in the USA it was reported that a 48 year old female received her fifth dose of IMOVAX RABIES vaccine, lot number W1419-3, administered IM at 3:30 AM on 4/2/04. The next day the patient developed a sore throat for three days. Reportedly the patient recovered from this experience.
Erythema, swelling and tactile warmth. The pt not seen by provider. Grandfather left with child before he could be seen by provider. 10/29/03 TC to grandmother. All symptoms resolved.
18 hours after my 2nd moderna vaccine, I experienced slurred speech.   When I arrived by car at my destination, I checked into a motel, looked into the mirror and noticed my left side of my face was drooping.   I knew this was sign of stroke.  I called 911 right away.  I was taken to hospital.  They did a CBC the night I arrived and the next day as well.  They did 2 cat scans with and without contrast.  Dr. in the ER determined that I had suffered a Transient Ischemic Attack which was brought on in less than 24hours of the 2nd Modern vaccine shot, and that the TIA was from the vaccine.  THe cat scans did not reveal any blood clots at the time of the scans.  Dr. concluded that they had broken up quickly and that was why  he diagnosed me with TIA.
Afternoon of flu shot developed chills and high fever. Patient passed out and ambulance called, taken to hospital.
depression; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEPRESSION (depression) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient had no health issues. The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DEPRESSION (depression). At the time of the report, DEPRESSION (depression) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The patient received the 1st 2 doses of Moderna COVID-19 Vaccine when the vaccine just came out, the caregiver does not remember the exact date but mentioned it was maybe on 2020. The lot number was unknown. The patient started feeling depressed after receiving the vaccines, the patient fell into a big depression that progressed slowly and felt out of space, and this had been going on for 2 years now, and it's getting worse, the patient was oblivious to everything. The patient needed to visit the doctor and they gave medications for depression but caller did not remember names. Previous to this situation, the patient was a healthy man.
Initial health care professional report received via license partner CSL Limited on 25 Feb 2011: This patient with an unknown medical history was vaccinated with MENVEO (manufacturer, strain and batch number: unknown), FLUVIRIN (manufacturer and batch number: unknown) and VARIVAX (batch number: unknown) on unspecified date (all on same day). After receiving the vaccinations the nurse also drew blood from patient. After drawing blood the patient fainted. He hit his head while fainting and was sent to emergency room (ER). The outcome was not reported.